>>
Industry>>
Bio tech>>
Role of Thromboxane A2 (TXA2) ...Our body’s immune system is meant to protect the body from harmful invaders, like pathogens, bacteria, toxins, etc. However, various genetic factors, smoking, infections, hormonal changes, and immune system abnormalities cause the immune system to become overactive. As a result, it mistakenly starts to attack the body’s healthy cells and leads to autoimmune disorders, like rheumatoid arthritis (RA).
Unlike osteoarthritis, RA primarily affects the lining of the joints, known as the synovial membrane. As a result, it leads to:
Over time, the inflammation leads to joint deformity, loss of function, and disability if not managed properly. While there is no permanent cure, modern therapies can slow or stop joint damage and help patients live their lives easily.
That is why early detection and proper treatment are the key to treating RA. Here is where the thromboxane A2 (TXA2) ELISA kit comes into play.
In order to understand the mechanism of RA and develop targeted therapies, researchers rely on biochemical markers that affect the underlying inflammatory and immune response.
In RA, thromboxane A2 (TXA2) acts as a biomarker that helps researchers assess disease activity, understand the inflammatory mechanism, and evaluate the treatment efficacy.
Thromboxane A₂ is a bioactive lipid derived from arachidonic acid through the cyclooxygenase (COX) pathway. It belongs to a family of eicosanoids that play critical roles in inflammation, platelet activation, and vascular function. TXA₂ is mainly produced by activated platelets, but immune cells such as macrophages and synovial fibroblasts in RA also generate significant amounts of it.
TXA₂ has two major biological functions:
Because TXA₂ is highly unstable, it rapidly hydrolyzes to a more stable form, Thromboxane B₂ (TXB₂). Researchers, therefore, use the TXA2 ELISA kit to measure TXB₂ levels as an indirect but reliable indicator of TXA₂ production.
RA is mainly driven by long-term inflammation in the joints. This inflammation increases the production of TXA₂. Since TXA₂ quickly breaks down, the kit measures the amount of TXB₂, which is further used to detect the quantity of TXA₂ in blood, plasma, or joint fluid.
This helps researchers:
By analyzing the results, researchers further analyze the disease progression in the body.
TXA₂ is produced through the COX (cyclooxygenase) pathway. This pathway also contributes to the production of other inflammatory molecules. Many common RA medicines, like NSAIDs, work by blocking COX enzymes.
Researchers use the TXA₂ ELISA kit to:
This information helps them decide whether a treatment is truly reducing inflammation at the biochemical level.
New therapies for RA are being studied every year. These include herbal compounds, biologic drugs, and platelet-related treatments. To know whether these treatments work, scientists must measure changes in TXA₂ levels.
The ELISA kit helps them compare TXA₂ levels:
If TXA₂ levels drop, it means the treatment is effective and helps reduce inflammation.
Sometimes blood tests alone are not enough. The real changes happen inside the joints. Researchers can use the TXA₂ ELISA kit to test synovial fluid. This fluid is found inside swollen or painful joints.
Testing this fluid helps researchers see:
These results provide a more accurate and detailed view of RA progression and help researchers determine the ideal treatment for each patient.
Now that you know how the TXA2 ELISA kit helps in RA research, what are you waiting for? Find a trusted source to buy a high-quality ELISA kit that can support your project and provide you with accurate and reliable results!